1-3 of 3
Zach Gill
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase I Trial Combining Venetoclax with Cladribine, Cytarabine, G-CSF, and Mitoxantrone (CLAG-M) for Patients with Acute Myeloid Leukemia (AML) and High-Grade Myeloid Neoplasms

Suravi Raychaudhuri, Ted Gooley, Allegra Rasmussen, Kim Quach, Zach Gill, Anna B. Halpern, Jacob S. Appelbaum, Cristina Maria Ghiuzeli, Paul C. Hendrie, Ryan D. Cassaday, Roland B. Walter, Elihu Estey, Mary-Elizabeth M. Percival
Journal: Blood
Blood (2024) 144 (Supplement 1): 4288.
https://doi.org/10.1182/blood-2024-200883
Published: 2024
Journal Articles

Phase I Trial Combining Venetoclax with G-CSF, Cladribine, Cytarabine, and Mitoxantrone (CLAG-M) for Patients with High-Grade Myeloid Neoplasms

Suravi Raychaudhuri, Ted Gooley, Zach Gill, Allegra Rasmussen, Anna B. Halpern, Jacob S. Appelbaum, Cristina Maria Ghiuzeli, Paul C. Hendrie, Ryan D Cassaday, Roland B. Walter, Elihu Estey, Mary-Elizabeth M. Percival
Journal: Blood
Blood (2023) 142 (Supplement 1): 2897.
https://doi.org/10.1182/blood-2023-181582
Published: 2023
Journal Articles

Serial HLA-Antibody Testing Identifies Waning Calculated Panel Reactive Antibodies (cPRA) in Platelet Transfusion Refractory Patients with Hematologic Malignancies

Kanak Parmar, Hamilton C Tsang, Danny Youngs, Zach Gill, Rida A. Hasan, Monica B. Pagano, John R. Hess, Terry B. Gernsheimer, Idoia Gimferrer, Sandhya Panch
Journal: Blood
Blood (2022) 140 (Supplement 1): 8566–8567.
https://doi.org/10.1182/blood-2022-170886
Published: 2022